
Our customers have had a great year, so (as it says on the cover) they've given us some great stories to tell.
This edition of Accelerate is a compilation of some of our customers' best stories from Callaghan Innovation's 2015/16 Annual Report.
If you want to read our entire report, download it here: Callaghan Innovation Annual Report 2016
Breathe EasyCystic fibrosis is a genetic illness affecting the lungs and digestive systems of approximately 75,000 people worldwide. Citramel, a newly developed inhaled drug from New Zealand company Breathe Easy, has the potential to improve radically the longevity and quality of these people’s lives. More... |
MethvenMethven celebrates 130 years of innovation in 2016 and has recently set out plans to grow the business to $130 million revenue by June 2018. More... |
ArchgolaArchgola is the leading supplier of awnings and shade solutions in New Zealand; their unique selling proposition is being the first company to develop shade shelter strictly for New Zealand conditions. Read more... |
AgritechIn April 2016, on a mission to promote their world-leading position, 23 New Zealand agritech businesses travelled to California on a week-long, Callaghan Innovation-led venture. More... |
Rocket LabCallaghan Innovation recognised a unique opportunity and provided help with the funding that Rocket Lab needed to get off the ground. More... |
Matariki XAs the seven stars of the Pleiades rose in the sky during Matariki 2016, fourteen stars of Māori innovation and business descended on Rotorua for Matariki X, a one-day Māori Inspire event. More... |
C-PrizeIn April 2015, having spotted an opportunity to further boost NZ's position as a leading developer of unmanned aerial vehicle (UAV) technology, Callaghan Innovation launched its first C-Prize competition. More... |
Updated: 20 November 2018